RESPeRATE device study shows benefits for Heart Failure patients - 03-Oct-2011

Results of a 72-patient controlled study of RESPeRATE, from InterCure, demonstrate that device–guided respiratory modulation with RESPeRATE applied at home can significantly relieve symptoms of Heart Failure in elderly patients. RESPeRATE is an FDA-cleared, CE-marked device indicated for the adjunctive treatment of hypertension for use as a relaxation aid by leading the user through interactively guided and monitored breathing exercises. The new study found that after 4 weeks of twice daily 20 minute at-home treatment sessions with RESPeRATE, patients who modified the breathing as directed by the device demonstrated a reduction in the severity of chronic Heart Failure measured by New York Heart Association (NYHA) classification, and in Dyspnea (shortness of breath) that is the major reason for seeking care in the chronic Heart Failure population. The observed reduction was significant by both its absolute mean and in comparison with control group and/or with patients, who didn't modify breathing as directed by the device. The results were published in the European Journal of Heart Failure (2011) 13 (9): 1000-1005).